Texas A&M University
College Station, Texas
I have academic, pharmaceutical industry and regulatory (7 years of service as a scientist and CMC reviewer in FDA) experiences. My research at FDA was focused on regulatory sciences to support Chemistry, Manufacturing and Controls (CMC), and the biopharmaceutics sections of NDAs and ANDAs. I have had the privilege to serve as grants reviewer, FDA liaison to USP Expert Committee on Excipients and scientist in ‘Immediate Release/Modified Release Work Group’ in FDA. I also worked in pharmaceutical industry for more than two years in the pharmaceutical development of various dosage forms for FDA’s approval. My research areas are: 1) discriminatory dissolution methods development and dissolution kinetic models; 2) formulation and process design of complex drug delivery systems (such as microparticles, implant, pediatric, nano-suspension, nanoemulsions, emulsions, emulsions, ointments and creams etc.); 3) 3-dimensional printing of various dosage forms for pharmaceutical application; and 4) design and evaluation of abuse deterrent formulations (ADF) for opioid analgesics.